TY - JOUR
T1 - Clinical analysis of bacterial strain profiles isolated from urinary tract infections
T2 - A 30-year study
AU - Wada, Koichiro
AU - Uehara, Shinya
AU - Yamamoto, Masumi
AU - Sadahira, Takuya
AU - Mitsuhata, Ritsuko
AU - Araki, Motoo
AU - Kobayashi, Yasuyuki
AU - Ishii, Ayano
AU - Kariyama, Reiko
AU - Watanabe, Toyohiko
AU - Nasu, Yasutomo
AU - Kumon, Hiromi
N1 - Publisher Copyright:
© 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - Objectives: We analyzed bacterial strains isolated from urine samples of patients with urinary tract infections (UTI) at Okayama University Hospital over a 30-year period to characterize trends in species and antimicrobial susceptibilities. Methods: Clinical isolates were collected from in- and out-patients with pyuria and bacteriuria who were treated between 1984 and 2014 (one episode per patient and plural isolates were counted in polymicrobial infection). We examined these isolates to identify pathogens and tested for antimicrobial susceptibility. Results: Isolates from complicated UTI over a 30-year period revealed Pseudomonas aeruginosa (P. aeruginosa) was the most frequently isolated in the first decade (1984-1994), MRSA in the second decade (1995-2004), and Escherichia coli (E. coli) in the latest decade (2005-2014). In uncomplicated UTI examined over 20 years, E. coli was the most frequently isolated species accounting for 47-94% of isolates. Fluoroquinolone (FQs)-insusceptible E. coli were first isolated in 1994 and increased to about 35% in 2013 in patients with complicated UTI. Conclusions: Complicated UTI involving P. aeruginosa and MRSA decreased over the last 10 years. Our data suggest that several factors such as shorter hospitalizations, shorter indwelling catheter use, and appropriate antimicrobial use has decreased colonization of P. aeruginosa and MRSA with relative increases in isolation of E. coli including FQs-insusceptible strains.We must continue our surveillance of antimicrobial-resistant bacteria isolated from urine samples and evaluate antibiograms, since their persistence in the urinary tract would be problematic.
AB - Objectives: We analyzed bacterial strains isolated from urine samples of patients with urinary tract infections (UTI) at Okayama University Hospital over a 30-year period to characterize trends in species and antimicrobial susceptibilities. Methods: Clinical isolates were collected from in- and out-patients with pyuria and bacteriuria who were treated between 1984 and 2014 (one episode per patient and plural isolates were counted in polymicrobial infection). We examined these isolates to identify pathogens and tested for antimicrobial susceptibility. Results: Isolates from complicated UTI over a 30-year period revealed Pseudomonas aeruginosa (P. aeruginosa) was the most frequently isolated in the first decade (1984-1994), MRSA in the second decade (1995-2004), and Escherichia coli (E. coli) in the latest decade (2005-2014). In uncomplicated UTI examined over 20 years, E. coli was the most frequently isolated species accounting for 47-94% of isolates. Fluoroquinolone (FQs)-insusceptible E. coli were first isolated in 1994 and increased to about 35% in 2013 in patients with complicated UTI. Conclusions: Complicated UTI involving P. aeruginosa and MRSA decreased over the last 10 years. Our data suggest that several factors such as shorter hospitalizations, shorter indwelling catheter use, and appropriate antimicrobial use has decreased colonization of P. aeruginosa and MRSA with relative increases in isolation of E. coli including FQs-insusceptible strains.We must continue our surveillance of antimicrobial-resistant bacteria isolated from urine samples and evaluate antibiograms, since their persistence in the urinary tract would be problematic.
KW - Antibiogram
KW - Antimicrobial susceptibility
KW - Fluoroquinolone-insusceptible Escherichia coli
KW - Urinary tract infection
UR - http://www.scopus.com/inward/record.url?scp=84969132838&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969132838&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2016.04.004
DO - 10.1016/j.jiac.2016.04.004
M3 - Article
C2 - 27217185
AN - SCOPUS:84969132838
SN - 1341-321X
VL - 22
SP - 478
EP - 482
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 7
ER -